Retatrutide 20mg — Certificate of Analysis (Aug 2026)
Certificate of Analysis for Retatrutide 20mg.
Sample identification
- Product
- Retatrutide
- Vial strength
- 20mg
- COA number
- HBL-20260806-KAYM-01
- Lot number
- HBL-20260806-KAYM
- Testing laboratory
- KMD Analytical
- Date received
- August 6, 2026
- Date reported
- August 14, 2026
Purity and quality analysis
- Average purity
- 99.93%
- Test method
- HPLC (chromatographic purity, % of total peak area)
- Identity
- Conforms — retention time + UV vs. reference standard
- Net peptide
- 20.01 mg/vial
- Appearance
- Conforms to specification
Source document
The values above are transcribed from the certificate issued by the testing laboratory. The original document is available below.
Test history for this product
Previous lots are retained rather than replaced, so material purchased earlier remains verifiable.
| Strength | Lot | Purity | Reported | Certificate |
|---|---|---|---|---|
| 10mg | HBL-20260806-2PJM | 98.67% | August 14, 2026 | View certificate |
This compound is intended exclusively for in vitro and ex vivo laboratory research by qualified scientific personnel. It is not approved for human or animal administration and is not a drug, dietary supplement, or therapeutic agent. No information on this page constitutes medical advice or dosage guidance.
By purchasing, you represent that you are a qualified researcher using this material solely for lawful laboratory research purposes and in compliance with all applicable laws. See our Research Use Policy for full terms.